SCHEMBL7423692

SCHEMBL7423692

CCCc1c(C(=O)COC)c2ccc(C(N)=O)cc2n1Cc1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.41
PLA2G2A P14555 4/20 0.40
DPP4 P27487 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CNR2 P34972 1/20 0.38
F2RL3 Q96RI0 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MITF O75030 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471716 0.92 ALOX5AP (0.41) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7421847 0.91 ALOX5AP (0.43) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7420896 0.90 LMNA (0.40) PLA2G2ACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7424518 0.90 ALOX5AP (0.43) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7426692 0.89 ALOX5AP (0.43) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7422341 0.88 TP53 (0.41) PLA2G2AKMT2AMEN1TP53RXFP1
SCHEMBL7424199 0.88 PLA2G2A (0.34) ALOX5APPLA2G2ATP53RXFP1
SCHEMBL7420485 0.88 ALOX5AP (0.42) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7424858 0.88 L3MBTL1 (0.47) ALOX5APPLA2G2ADPP4CYP1A2CYP3A4
SCHEMBL7421169 0.87 PLA2G2A (0.43) ALOX5APPLA2G2ADPP4CNR2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed